logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Gho Capital Invests In Biocare Medical, A Global Leader In Oncology-Focused Diagnostic Reagents And Instrumentation

Dec 09, 2021•about 4 years ago
London

Description

Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare, announces its investment in Biocare Medical (“Biocare”), a leading developer of world-class immunohistochemistry (“IHC”) and in situ hybridization (“ISH”) reagents for cancer diagnosis and chromosomal profiling. Existing investor Excellere Partners, a US-based private equity firm shall remain a significant partner in the company alongside GHO.

Company Information

Company

Biocare Medical

Location

London, Ontario, Canada

About

Biocare is a market leader in IHC and molecular diagnostic reagents and instrumentation, including simultaneous Multiplex IHC solutions that provide increased confidence at critical diagnostic decision points, positively influencing patient therapy while accelerating turnaround time. The company’s customers include clinical and hospital laboratories, pharmaceutical and biotechnology companies, as well as academic, government, and other research institutions. Biocare offers a comprehensive portfolio of integrated reagents and instrumentation to address the rapidly growing diagnostic and research markets for oncology and immunotherapy. The company is headquartered in Pacheco, CA, and serves customers around the globe. Visit www.biocare.net to learn more.